Seegene HOME > Company > Investor relations > IR news
IR NEWS
  • Seegene Signs Research Agreement with H1N1 Cross-Agencies Task Force
  • 등록일
  • 2012-01-31

Seegene Signs Research Agreement with H1N1 Cross-Agencies Task Force

Seegene signed a research agreement with H1N1 Cross-Agencies Task Force (headed by professor Woojoo Kim, Division of Infectious Diseases, Korea Univ. Guro Hospital) on the establishment of a rapid diagnostic technique and medium and long-term epidemiological / clinical research to secure fundamental technology to address the threat of respiratory virus pandemics that require national preparation due to their high infectivity and fatality.

Through this agreement, Seegene and the H1N1 Cross-Agencies Task Force will cooperate with each other in the epidemiological investigation and clinical research of respiratory infection by using respiratory virus diagnosis products, the development of diagnosis products of new strains of viruses to enable quick diagnoses in an H1N1 pandemic, and the research of diagnostic techniques for respiratory infections other than influenza. In addition, both parties will strengthen their research collaboration relationship by actively exchanging academic research and technical information to establish the systematic diagnoses of respiratory viruses.

  • no
  • cont
  • title
  • date
63 NEWS Investor relations Jun 17 to 18, 2013 (London) 2013-06-17
62 NEWS Seegene Selected as the ‘KOSDAQ Hidden Champion’ for its Thir... 2013-05-01
61 NEWS Seegene Licenses Multiplex Assay Technologies to bioMerieux 2013-04-16
60 NEWS Seegene signs Supply Contract with Synlab Holding GmbH 2013-03-11
59 NEWS Seegene Signs Strategic Partnership with SK Telecom 2013-01-17
SEARCH
side 배너 씨젠소개부분
Simultaneous detection of 16 viruses using...
Obtained CE-IVD marking for Anyplex™ Flu...
Launched Anyplex™ TV/MH Real-time Detect...
Detection of T. vaginalis and M. hominis